Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunish Shah

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Medical Informatics|September 21, 2020
Optimizing the correct timing of vancomycin level collection utilizing a vancomycin medication administration record (MAR) level orderSunish Shah, Ginger E Rouse, Dayna McManus, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 6, 2024
Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patientsMatthew Ringer, Maricar Malinis, Dayna McManus, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
The changing epidemiology and long-term outcomes of patients with CRE infectionsSunish Shah, Lloyd G Clarke, Erin K McCreary, et al.
The Journal of Antimicrobial Chemotherapy|July 27, 2020
Clinical outcomes of baloxavir versus oseltamivir in patients hospitalized with influenza ASunish Shah, Dayna McManus, Nika Bejou, et al.
International Journal of Antimicrobial Agents|December 12, 2024
Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infectionsSunish Shah, Kathleen Adams, Lloyd Clarke, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactamsAva J Dorazio, Ellen G Kline, Kevin M Squires, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2023
Serratia endocarditis: antimicrobial management strategies and clinical outcomesSunish Shah, Madeline McCrary, Asher J Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or PneumoniaSunish Shah, Ellen G Kline, Ghady Haidar, et al.
Open Forum Infectious Diseases|November 29, 2023
Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic ShockMatthew O'Donnell, Ryan K Shields, Rachel V Marini, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Medical Informatics|September 21, 2020
Optimizing the correct timing of vancomycin level collection utilizing a vancomycin medication administration record (MAR) level orderSunish Shah, Ginger E Rouse, Dayna McManus, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 6, 2024
Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patientsMatthew Ringer, Maricar Malinis, Dayna McManus, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
The changing epidemiology and long-term outcomes of patients with CRE infectionsSunish Shah, Lloyd G Clarke, Erin K McCreary, et al.
The Journal of Antimicrobial Chemotherapy|July 27, 2020
Clinical outcomes of baloxavir versus oseltamivir in patients hospitalized with influenza ASunish Shah, Dayna McManus, Nika Bejou, et al.
International Journal of Antimicrobial Agents|December 12, 2024
Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infectionsSunish Shah, Kathleen Adams, Lloyd Clarke, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactamsAva J Dorazio, Ellen G Kline, Kevin M Squires, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2023
Serratia endocarditis: antimicrobial management strategies and clinical outcomesSunish Shah, Madeline McCrary, Asher J Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or PneumoniaSunish Shah, Ellen G Kline, Ghady Haidar, et al.
Open Forum Infectious Diseases|November 29, 2023
Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic ShockMatthew O'Donnell, Ryan K Shields, Rachel V Marini, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
Pageof 5